Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 6/2018

01-06-2018 | Letter to the editor

Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses

Authors: Peter Dalgaard, Claus Thorn Ekstrøm, Dorte Kronborg

Published in: Supportive Care in Cancer | Issue 6/2018

Login to get access

Excerpt

To the Editor of Supportive Care in Cancer, …
Literature
1.
2.
R Core Team (2016). R: a language and environment for statistical computing. Vienna, Austria
Metadata
Title
Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses
Authors
Peter Dalgaard
Claus Thorn Ekstrøm
Dorte Kronborg
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 6/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3859-5

Other articles of this Issue 6/2018

Supportive Care in Cancer 6/2018 Go to the issue

Original Article

Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach

Commentary

Sexual health in patients with hematological malignancies: a neglected issue

Original Article

Attitudes towards end-of-life issues in intensive care unit among Italian anesthesiologists: a nation-wide survey

Original Article

Influence of family on expected benefits of complementary and alternative medicine (CAM) in cancer patients

Original Article

Breast cancer survivor’s perspectives on the role different providers play in follow-up care

Original Article

Applying pre-participation exercise screening to breast cancer survivors: a cross-sectional study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits